Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 批发和零售业
Company Introduction 浙江英特集团股份有限公司主营药品、中药材、医疗器械的销售,是一家医药流通企业,旗下拥有英特药业、英特医药物流和英特医疗器械等控股子公司.为突破企业发展的瓶颈,公司于06年初斥资1亿元打造英特药业产业基地,此次打造的英特药业基地建成后将设立中药饮片加工基地、3万平米大型医药物流配送中心、医药贸易中心和行政管理总部.该基地将可支持50亿元的销售物流保障,并最终提供100亿元销售的物流能力。
Main Business 从事药品、中药、生物制品、医疗器械批发及零售业务，涵盖医药分销、终端零售、现代物流、电子商务等多种业态，即从上游医药生产或供应企业采购产品，然后再批发给下游的医疗机构、药店、经销商等或通过零售终端直接销售给消费者。
Legal Representative 应徐颉
Top Executives
董事长：应徐颉
董事：应徐颉,郭俊煜,张建明,刘琼,李晓光,汪洋,谌明
独立董事：李耀,余军,黄英,陈昊
Top 5 Shareholder
Shareholder name Nature Holding Date
浙江省国际贸易集团有限公司限售股+流通A股28.89%30/09/2024
浙江华辰投资发展有限公司限售股+流通A股23.42%30/09/2024
华润医药商业集团有限公司流通A股11.44%30/09/2024
浙江康恩贝制药股份有限公司限售股9.37%30/09/2024
迪佛电信集团有限公司流通A股1.54%30/09/2024
Company Secretary 谭江
Solicitors 浙江天册律师事务所
Auditors 大华会计师事务所（特殊普通合伙）
Tel No 0571-86022582;0571-85068752
Fax No 0571-85068752
Website www.intmedic.com
Email tanjiang2009@foxmail.com；qiuli000411@163.com
Company Address
Register: 杭州市下城区东新路江南巷2号3幢
Office: 浙江省杭州市滨江区江南大道96号中化大厦
Listing Date 16/07/1996
Shares Capital
Shares Capital: 522,149,575
Total A Share: 522,149,575
Listed A Share: 320,977,611
Non-tradable A Share: 201,171,964
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.090
DPS(RMB)* ¥ 0.305
NBV Per Share(RMB)* ¥ 8.000
Market Capitalization(RMB) 3.589B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.